Dental Implants for Diabetics: Success Rates and UK Guidance

Dental implants for diabetics succeed at rates close to non-diabetic patients when blood glucose is well controlled, with most UK studies and meta-analyses placing five year survival between 93 and 97 percent in patients whose HbA1c sits at or below 7 percent. The gap widens, sometimes sharply, once control slips above 8 percent. This guide is about the numbers behind that statement: what the published success rates actually are, how they shift with glycaemic control, and the clinical guidance UK surgeons follow to keep a diabetic implant in the good column.

TL;DR

For UK patients with diabetes, the headline figure is reassuring. Well controlled diabetics (HbA1c at or below 7 percent) see implant survival of roughly 93 to 97 percent at five years and around 90 to 95 percent at ten years, only marginally below non-diabetic patients. Poorly controlled diabetics (HbA1c above 8 percent) drop to 86 to 89 percent survival and carry roughly double the rate of peri-implantitis. Success is driven far more by glycaemic control, smoking status and gum health than by the diabetes label itself. UK surgeons work to HbA1c targets, liaise with your GP, allow longer healing windows and put diabetic patients on tighter hygiene recalls. This article focuses on the evidence and the protocols; for a broader patient overview, see our companion piece on diabetes and dental implants for UK patients.

What "success" actually means in the implant literature

Before any survival percentage means anything, it helps to know what researchers are counting. The implant world uses two related but different ideas, and clinics sometimes blur them in marketing.

Survival means the implant is still in the mouth. It has not been removed and is still carrying a crown, bridge or denture. Survival is the easier number to measure and the one most often quoted.

Success is stricter. The most widely used definition still traces back to the Albrektsson criteria: the implant is immobile, there is no continuous radiolucency around it, bone loss is below roughly 0.2 mm per year after the first year, and there is no persistent pain, infection or numbness. An implant can survive while failing the success test, for example one that is stable but slowly losing bone to peri-implantitis.

This distinction matters most for diabetic patients, because the diabetic risk is concentrated in the soft tissue and bone around the implant rather than in catastrophic early loss. A diabetic implant is more likely to survive but score as a partial success because of marginal bone loss over the years. When you read a clinic claiming "98 percent success," ask whether they mean survival or strict success, and over how many years.

Dental implants diabetics success rate: the evidence by control band

The strongest evidence comes from systematic reviews and meta-analyses on PubMed that pool dozens of cohorts and stratify patients by glycaemic control. Reading across the major reviews published over the last decade, a consistent pattern emerges.

Non-diabetic baseline. Implant survival in healthy adults sits at roughly 95 to 99 percent at five years and 90 to 95 percent at ten years. This is the benchmark every diabetic figure is measured against.

Well controlled diabetes (HbA1c at or below 7 percent / 53 mmol/mol). Survival of around 93 to 97 percent at five years. Several reviews find no statistically significant difference from non-diabetic controls at this level of control. The clinical reading is simple: a tightly controlled diabetic is, for implant purposes, close to an ordinary patient.

Moderately controlled diabetes (HbA1c 7 to 8 percent). Survival typically in the low 90s, with a measurable rise in early healing complications and delayed osseointegration. Most UK surgeons will treat in this band but with extra caution and a longer healing timetable.

Poorly controlled diabetes (HbA1c above 8 percent / 64 mmol/mol). Survival drops to roughly 86 to 89 percent at five years in pooled data, and peri-implantitis rates roughly double compared with well controlled patients. Early failure (before the crown is even fitted) becomes meaningfully more common because new bone forms more slowly and less reliably.

A few caveats make these numbers honest. Many studies are observational rather than randomised, follow-up varies, and patients with very high HbA1c are often excluded from treatment in the first place, which can flatter the published survival figures. The direction of the evidence is not in doubt, though: control predicts outcome, and the relationship is roughly linear above 7 percent.

Why control, not the diabetes label, drives the numbers

The mechanism explains the statistics. Persistently raised glucose produces advanced glycation end products that interfere with osteoblasts, the cells that lay down the new bone an implant needs to integrate. High glucose also impairs neutrophil function, thickens small blood vessel walls and reduces the oxygen and nutrient supply to the healing wound. The result is slower, less predictable osseointegration and a gum environment that favours the bacteria behind peri-implantitis.

The NHS guidance on Type 2 diabetes and oral health is blunt about the gum disease link, and gum disease around an implant is precisely the late failure mode that the long-term data captures. Our explainer on what osseointegration is and the biology behind a lasting implant walks through the healing biology in more detail, and it is worth reading alongside this piece because the diabetic risk is really a story about how that one process is slowed.

Because the driver is biological rather than diagnostic, a patient with well managed Type 1 diabetes who does not smoke can have a better prognosis than a non-diabetic smoker with untreated gum disease. The diabetes label sets the planning, but day-to-day control sets the outcome.

HbA1c targets and the UK traffic light approach

UK implant surgeons translate the evidence into a simple framework before quoting firm dates. HbA1c is the blood test that reflects average glucose over the previous 8 to 12 weeks, and clinics will want a result from within the last three months.

Below 7 percent (53 mmol/mol): green, treat as standard with diabetic aftercare
7 to 8 percent (53 to 64 mmol/mol): amber, treat with caution, longer healing windows
Above 8 percent (64 mmol/mol): red, optimise with your GP before surgery
Above 9 percent (75 mmol/mol): defer until control improves

The Royal College of Surgeons of England Faculty of Dental Surgery and the British Dental Association both advise liaison with the patient's diabetes team when HbA1c sits above 8 percent. A surgeon who quotes you firm placement dates without asking for a recent HbA1c is skipping the single most predictive piece of information they have. If a quote feels rushed or skips this step, our guide on how to spot a dodgy dental implant quote is a useful sense-check.

Complication odds beyond simple survival

Survival is only one outcome. For diabetic patients, three other measures shape the real experience, and the guidance addresses each.

Peri-implantitis. This is the inflammatory bone loss around an integrated implant, and it is where the diabetic disadvantage concentrates. Pooled cohorts indexed on PubMed report roughly double the peri-implantitis rate at ten years in diabetic versus non-diabetic patients, with the gap widening at higher HbA1c. It is the main reason a diabetic implant survives but scores as a partial success. Our piece on dental implant infection risk and UK data sets these figures in the context of the whole UK population.

Early failure. Failure before the restoration is fitted is more common above 8 percent HbA1c because early bone formation is impaired. Below 7 percent, early failure rates approach non-diabetic levels.

Delayed integration. Healthy adults integrate an implant in roughly 8 to 16 weeks. Diabetic patients, particularly in the softer bone of the upper jaw, may need 16 to 24 weeks. This is not a failure, it is a planning input, and it is why staged treatment plans run longer for diabetics.

The practical takeaway is that the diabetic risk is manageable and largely deferred into the maintenance years, which is exactly why aftercare is treated as part of the treatment rather than an afterthought.

Pre-operative optimisation: the clinical guidance

The most useful thing a diabetic patient can do for their success rate happens before any drill touches bone. UK guidance centres on a short optimisation phase.

Confirm and, if needed, improve HbA1c. Aim for at or below 7 percent. A three to six month window working with your GP or diabetes nurse to bring HbA1c down from, say, 8.5 to 7 can change the next twenty years of outcomes.
Stabilise the gums. Active periodontitis must be fully treated and stable for at least three months, with plaque scores below 20 percent and no bleeding on probing at the planned site. Placing an implant into an inflamed mouth wastes the surgery.
Image properly. Expect an OPG radiograph and usually a CBCT scan to assess bone volume and quality, which matters because diabetic bone can be slower to remodel. Where bone is short, a bone graft or, in the upper back jaw, a sinus lift may be planned in first.
Review the whole picture. Blood pressure, diabetes complications (eye, kidney, foot, heart), smoking and alcohol history, and a full medication list all feed the plan.
Write to your GP. A signed letter or e-mail confirming the plan and any peri-operative medication changes is standard practice and protects both patient and surgeon.

Perioperative and surgical guidance specific to diabetics

On the day and around it, UK protocols adapt in ways that quietly protect the success rate.

Timing. Surgery is usually scheduled for the morning, after a normal insulin dose and breakfast for insulin-treated patients, with hypoglycaemia prevention as the main same-day concern.

Medications. Most diabetes drugs continue through implant surgery, but a few need attention. SGLT2 inhibitors such as empagliflozin and dapagliflozin are commonly paused 24 to 72 hours beforehand to reduce ketoacidosis risk. GLP-1 agonists such as semaglutide and tirzepatide delay gastric emptying and may need a short pause if intravenous sedation is planned. Metformin generally continues and may even support healing. Always bring a full, current medication list.

Antibiotic and antiseptic cover. Many UK surgeons use a pre-operative antibiotic and a chlorhexidine rinse for diabetic cases, reflecting the higher infection risk, though practice varies and is a clinical judgement.

Healing windows. Longer integration times are built in. A staged plan that runs three to four months for a non-diabetic patient may run four to six months for a diabetic one. Immediate loading is approached more cautiously; if you are weighing it, our piece on immediate load dental implants, pros, cons and UK availability is worth reading.

Surgical technique. Atraumatic technique, careful flap handling and avoiding overheating the bone matter more when healing capacity is reduced. These are surgeon-side factors you cannot control directly, which is why choosing an experienced clinician on the GDC Online Register is itself a success-rate decision.

Type 1 versus Type 2: does it change the guidance?

Both types are compatible with implant treatment, and the survival evidence does not show a large gap between them once glycaemic control is matched. The guidance differs mainly in logistics.

Type 1 patients need a clear plan for insulin timing around surgery and for soft food afterwards, with hypoglycaemia the principal same-day risk. Type 2 patients are more likely to be on oral agents or GLP-1 drugs, so the medication review is the busier part of planning. Gestational diabetes is almost never a setting for elective implants; UK clinics typically wait until at least six months post-partum and confirm HbA1c has normalised.

Whichever type, the protocol converges on the same point: get control steady, stabilise the gums, plan a longer timeline, and maintain rigorously afterwards.

Maintenance: where the long-term success rate is won or lost

The ten year figures hinge on what happens after the crown goes on. For diabetic patients, the maintenance protocol is the difference between the 95 percent column and the 86 percent column.

Brush twice daily with a soft brush, plus interdental brushes and a single-tufted brush around the abutment collar
Three monthly professional hygiene visits in the first year, then six monthly, more often if HbA1c rises
Annual HbA1c review with your GP, treated as part of implant care
Never smoke; the risk compounds sharply when diabetes and smoking combine, as covered in our piece on smoking and dental implants and what clinics really ask
Manage dry mouth, which is common on multiple medications and raises plaque risk

Our dental implant cleaning and UK hygiene routine guide sets out the daily mechanics, and the first 30 days recovery guide covers the early healing period when diabetic wounds need the most attention.

NHS versus private routes and what they mean for outcomes

NHS implants are not routine. They are reserved for severe clinical need such as missing bone after cancer surgery, trauma or congenital absence, and diabetes by itself does not qualify a patient even when it contributed to tooth loss. Our NHS dental implants eligibility guide for 2026 walks through the criteria. In practice almost all diabetic patients go private, where the longer timeline and tighter recall schedule are easier to deliver and where the surgeon can build in the diabetic-specific protocols above.

There is no UK surcharge for being diabetic, although the extra hygiene visits and longer staging can add modest cost. For the numbers, our dental implants cost UK 2026 real numbers breakdown is the reference point, and many clinics spread fees with finance, compared in our 0 percent APR finance plans guide.

When UK surgeons defer treatment

Postponement is a tool for protecting the success rate, not a refusal. A UK surgeon will commonly defer when HbA1c is above 9 percent, when there is active untreated periodontitis, after a recent diabetes-related hospital admission, mid-way through a change of diabetes medication, or alongside uncontrolled hypertension or active heart disease. A three to six month delay to bring control down is one of the cheapest interventions available against a several thousand pound investment that depends on biology.

FAQ: Dental implants and diabetes success rates

What is the success rate of dental implants in diabetics?

In well controlled diabetics (HbA1c at or below 7 percent), implant survival is roughly 93 to 97 percent at five years and 90 to 95 percent at ten years, close to non-diabetic patients. In poorly controlled diabetics (HbA1c above 8 percent), survival falls to about 86 to 89 percent at five years and peri-implantitis rates roughly double. Control matters far more than the diabetes label.

Do type 2 diabetes implants fail more often than type 1?

The published evidence does not show a large difference between type 1 and type 2 once glycaemic control is matched. Both succeed at high rates when HbA1c is at or below 7 percent. The planning differs more than the outcome: type 1 focuses on insulin timing and hypoglycaemia prevention, while type 2 involves more medication review around drugs like metformin, GLP-1 agonists and SGLT2 inhibitors.

What HbA1c do I need for dental implants in the UK?

Most UK implant surgeons want HbA1c at or below 7 percent (53 mmol/mol). Treatment between 7 and 8 percent is common with extra caution and longer healing. Above 8 percent, surgery is usually deferred until your GP or diabetes team helps you optimise control, and above 9 percent it is generally postponed.

How much longer does a diabetic implant take to heal?

Healthy adults integrate an implant in roughly 8 to 16 weeks. Diabetic patients, especially in the softer bone of the upper jaw, may need 16 to 24 weeks. Many surgeons run a staged plan of four to six months from placement to final crown for diabetics, rather than three to four months for non-diabetic patients.

Does diabetes increase peri-implantitis after the implant succeeds?

Yes. The diabetic disadvantage concentrates in the maintenance years. Pooled UK and international cohorts report roughly double the rate of peri-implantitis at ten years in diabetic versus non-diabetic patients, with higher HbA1c widening the gap. Three monthly hygiene visits in the first year and tight glucose control prevent most of it.

Can poorly controlled diabetics ever have implants?

Surgeons will usually defer rather than refuse. The standard approach is an optimisation phase of three to six months with your GP to bring HbA1c down toward 7 percent, treat any active gum disease, and stop smoking. Once control improves, the success rate moves back toward the well controlled figures.

Final thoughts

The evidence on dental implants for diabetics is genuinely encouraging, and it is specific. With HbA1c at or below 7 percent, survival sits within a few percentage points of non-diabetic patients, and the late risk that does exist, mostly peri-implantitis, is largely controllable with disciplined maintenance. UK guidance turns that evidence into a clear sequence: optimise control before surgery, stabilise the gums, choose an experienced clinician on the GDC register, accept a slightly longer timeline, and treat three monthly hygiene as part of the package. Diabetes shapes the plan rather than blocking it, and for most well controlled patients the numbers come out close to everyone else's.